🎗️ OncologyTablet
Idhifa
Enasidenib
IDH2 inhibitor for relapsed or refractory acute myeloid leukemia with IDH2 mutation.
Form
Tablet
Uses
1
Side effects
5
Category
Oncology
01
What is Idhifa used for?
- Relapsed/refractory IDH2-mutated AML
02
Enasidenib side effects
Common side effects of Enasidenib include:
Nausea
Elevated bilirubin
Diarrhea
Reduced appetite
Leukocytosis
CommonModerateLess common
03
Enasidenib warnings & precautions
- Differentiation syndrome can be fatal. Monitor and treat with steroids
- Embryo-fetal toxicity
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Idhifa in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.